Company database
Eleva GmbH
Development of highly efficient biopharmaceuticals
We at Greenovation develop next generation therapeutics using our proprietary BryoTechnology platform.
Our core competency is optimization and effective production of highly-efficient glycoproteins for the treatment of orphan diseases.
GMP compliant manufacturing of our products is performed in Greenovation’s state-of-the-art facility operated by our partners BIOMEVA and BIBITEC.
Greenovation is a privately owned biopharmaceutical company based in Heilbronn, Germany, that was founded in 1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunter Neuhaus. Today, Zukunftsfonds Heilbronn and L-EigenkapitalAgentur, Karlsruhe, are main owners of the Greenovation Biotech GmbH.
Biotech CompaniesProteins/Peptides, Therapeutics, Contract Manufacturing/OEM, Cells/Cell Lines, Production Organisms
Further information on the websites of BIOPRO Baden-Württemberg: